Patient Access to Generics is in Jeopardy. Tell Congress to #BLOCK205!

Congress is considering a significant change right now that, if enacted, would put patient access to more affordable generic medicines in jeopardy. The BLOCKING Act (H.R. 938) and Section 205 (S. 1895) weaken the one incentive available to generics that encourages them to challenge brand-name drug patents. Without the incentive, patients will pay the high price of expensive brand-name drugs for longer.

Tell Congress to #BLOCK205 and protect patient access to safe, more affordable generic medicines.

Paid for by the Association for Accessible Medicines.

Tell Congress to #BLOCK205!